Extramammary Paget's disease screening
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]
Overview
Overview
According to the United States Preventive Services Task Force, screening for extramammary Paget’s disease is not recommended among the general population.
Screening
Screening
- Routine screening for extramammary Paget’s disease in general population is not recommended.[1]
- However, approximately 10% of patients with Paget’s disease of the vulva have an underlying second malignancy. These include colorectal cancer, cervical cancer, breast cancer, as well as carcinoma of the transitional epithelium from the renal pelvis to urethra. Routine screening with colonoscopy, Pap test, and mammogram may therefore be recommended in these patients.[2]
References
References
- ↑ http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=extramammary+pagets+disease Accessed on January 26, 2016.
- ↑ Onaiwu, Cherry O.; Ramirez, Pedro T.; Kamat, Ashish; Pagliaro, Lance C.; Euscher, Elizabeth E.; Schmeler, Kathleen M. (2014). “Invasive extramammary Paget’s disease of the bladder diagnosed 18years after noninvasive extramammary Paget’s disease of the vulva”. Gynecologic Oncology Case Reports. 8: 27–29. doi:10.1016/j.gynor.2014.03.004. ISSN 2211-338X.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH